Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=118"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=118

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00120289-13dc40ff",
        "title": "ERN + Simvastatin vs Placebo + Simvastatin: Composite End Point of CHD Death, Nonfatal MI, Ischemic Stroke, Hospitalization for Non-ST Segment Elevation Acute Coronary Syndrome (ACS), or Symptom-driven Coronary or Cerebral Revascularization",
        "summary": "282 of 1718 against 274 of 1696; risk difference 0.3 points, 95% interval -2.2 to 2.7; NCT00120289, Niacin Plus Statin to Prevent Vascular Events",
        "record": "/library/comparisons/NCT00120289-13dc40ff",
        "nct_id": "NCT00120289",
        "kind": "outcome",
        "participants": 3414,
        "risk_difference": {
          "value": 0.0025877501262986657,
          "lower": -0.022212514811306403,
          "upper": 0.02736597756856697
        },
        "group_1": "282 of 1,718",
        "group_2": "274 of 1,696",
        "difference": "0.3 points",
        "interval": "-2.2 to 2.7",
        "trial_title": "Niacin Plus Statin to Prevent Vascular Events"
      },
      {
        "id": "NCT00120289-5269d466",
        "title": "ERN + Simvastatin vs Placebo + Simvastatin: Cardiovascular Mortality",
        "summary": "45 of 1718 against 38 of 1696; risk difference 0.4 points, 95% interval -0.7 to 1.4; NCT00120289, Niacin Plus Statin to Prevent Vascular Events",
        "record": "/library/comparisons/NCT00120289-5269d466",
        "nct_id": "NCT00120289",
        "kind": "outcome",
        "participants": 3414,
        "risk_difference": {
          "value": 0.003787587585388892,
          "lower": -0.006711562320149066,
          "upper": 0.014356917572183837
        },
        "group_1": "45 of 1,718",
        "group_2": "38 of 1,696",
        "difference": "0.4 points",
        "interval": "-0.7 to 1.4",
        "trial_title": "Niacin Plus Statin to Prevent Vascular Events"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=119",
  "request_id": "-WE94078HFTh_hfX"
}